Rosuvastatin

Product NDC
69238-1148
11-digit product format
692381148
Labeler code
69238
Product ID
69238-1148_da716d5f-ee56-4911-95c9-87d4529067e9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Rosuvastatin
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Amneal Pharmaceuticals NY LLC
Application
ANDA208850
Marketing category
ANDA
Marketing start
2018-10-22
Marketing end
0000-00-00
Substance
ROSUVASTATIN CALCIUM
Active strength
20 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct69238-1148DDiscontinued by firm2026-10-05
excluded packagepackage69238-114869238-1148-9DDiscontinued by firm2026-10-05

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A208850-001ROSUVASTATIN CALCIUMROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-16
A208850-002ROSUVASTATIN CALCIUMROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-16
A208850-003ROSUVASTATIN CALCIUMROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-16
A208850-004ROSUVASTATIN CALCIUMROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A208850-001ROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-1684e616aacf4f…
2026-09-14 22:38:342026-08A208850-002ROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-1684e616aacf4f…
2026-09-14 22:38:342026-08A208850-003ROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-1684e616aacf4f…
2026-09-14 22:38:342026-08A208850-004ROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-1684e616aacf4f…
2026-08-18 06:07:402026-07A208850-001ROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-16caaa826d4ba7…
2026-08-18 06:07:402026-07A208850-002ROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-16caaa826d4ba7…
2026-08-18 06:07:402026-07A208850-003ROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-16caaa826d4ba7…
2026-08-18 06:07:402026-07A208850-004ROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-16caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A208850-001ROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02A208850-002ROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02A208850-003ROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02A208850-004ROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208850-001ROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208850-002ROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208850-003ROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208850-004ROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08A208850-001ROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08A208850-002ROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08A208850-003ROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08A208850-004ROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-166a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A208850-001ROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-16fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A208850-002ROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-16fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A208850-003ROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-16fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A208850-004ROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-16fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A208850-001ROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-16b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A208850-002ROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-16b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A208850-003ROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-16b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A208850-004ROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-16b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A208850-001ROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-1603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A208850-002ROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-1603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A208850-003ROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-1603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A208850-004ROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-1603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A208850-001ROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-162680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A208850-002ROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-162680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A208850-003ROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-162680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A208850-004ROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-162680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A208850-001ROSUVASTATIN CALCIUMEQ 5MG BASETABLET / ORAL2018-10-165bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A208850-002ROSUVASTATIN CALCIUMEQ 10MG BASETABLET / ORAL2018-10-165bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A208850-003ROSUVASTATIN CALCIUMEQ 20MG BASETABLET / ORAL2018-10-165bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A208850-004ROSUVASTATIN CALCIUMEQ 40MG BASETABLET / ORAL2018-10-165bbf6a4d5a75…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69238-1148ROSUVASTATIN TABLET, FILM COATED [AMNEAL PHARMACEUTICALS NY LLC]12Legacy NDC20241031_52435b49-6228-4a30-9992-2ea2e77ec7b1.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
69238-1148-96923811480990 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69238-1148-9) 2018-10-220000-00-00NoNoCurrent